Comparisons of exacerbations and mortality among LAMA/LABA combinations in stable chronic obstructive pulmonary disease: systematic review and Bayesian network meta-analysis

BACKGROUND: Only few randomized controlled trials (RCTs) for head-to-head comparison have been conducted between various combinations of long-acting muscarinic antagonists (LAMAs) and long-acting beta-agonists (LABAs). Our study was conducted to compare acute exacerbation and all-cause mortality amo...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hyun Woo, Park, Jimyung, Jang, Eun Jin, Lee, Chang-Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687787/
https://www.ncbi.nlm.nih.gov/pubmed/33238986
http://dx.doi.org/10.1186/s12931-020-01540-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687787/
https://www.ncbi.nlm.nih.gov/pubmed/33238986
http://dx.doi.org/10.1186/s12931-020-01540-8

Ejemplares similares